Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Eur J Pharmacol ; 824: 40-47, 2018 Apr 05.
Article in English | MEDLINE | ID: mdl-29409910

ABSTRACT

NO plays a key role in the pathological mechanisms of articular diseases. As cytoskeletal proteins are responsible for the polymerization, stabilization, and dynamics of the cytoskeleton network, we investigated whether cytoskeletal proteins are the intracellular pathological targets of NO. We aimed at clarifying whether the cytoskeleton perturbations involved in apoptosis are induced in rabbit articular chondrocytes by NO, which can be liberated by sodium nitroprusside (SNP) treatment. The first passage rabbit articular chondrocytes were cultured as monolayer for the experiments, and the effects of NO were tested in the presence of JNK-specific inhibitor, SP600125. SNP treatment of cultured chondrocytes caused significant apoptosis in a concentration-dependent manner (time and dose), as evaluated by TUNEL assay and Annexin V flow cytometry, while the apoptosis was reduced by the SP600125 addition 30 min before SNP treatment. Besides, SP600125 decreased significantly the protein expression of total caspase-3 and the intracellular gene expression of caspase-3, measured by Western blot analysis and PCR. SP600125 also increased the cytoskeletal protein expressions. These results suggested that JNK pathway plays a critical role in the NO-induced chondrocyte apoptosis, and SP600125 treatment blocks the dissolution of the cytoskeletal proteins via activation of caspase-3 pathways.


Subject(s)
Anthracenes/pharmacology , Apoptosis/drug effects , Caspase 3/metabolism , Chondrocytes/drug effects , Cytoskeletal Proteins/metabolism , Nitric Oxide/metabolism , Proteolysis/drug effects , Animals , Caspase 3/genetics , Chondrocytes/cytology , Chondrocytes/metabolism , Enzyme Activation/drug effects , Gene Expression Regulation/drug effects , JNK Mitogen-Activated Protein Kinases/antagonists & inhibitors , Protein Kinase Inhibitors/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rabbits , Signal Transduction/drug effects
2.
Biomed Environ Sci ; 30(5): 351-362, 2017 May.
Article in English | MEDLINE | ID: mdl-28549491

ABSTRACT

OBJECTIVE: To investigate chondrocyte apoptosis and the expression of biochemical markers associated with apoptosis in Kashin-Beck disease (KBD) and in an established T-2 toxin- and selenium (Se) deficiency-induced rat model. METHODS: Cartilages were collected from the hand phalanges of five patients with KBD and five healthy children. Sprague-Dawley rats were administered a selenium-deficient diet for 4 weeks prior to T-2 toxin exposure. The apoptotic chondrocytes were observed by terminal deoxynucleotidyl transferase dUTP nick end labeling staining. Caspase-3, p53, Bcl-2, and Bax proteins in the cartilages were visualized by immunohistochemistry, their protein levels were determined by Western blotting, and mRNA levels were determined by real-time reverse transcription polymerase chain reaction. RESULTS: Increased chondrocyte apoptosis was observed in the cartilages of children with KBD. Increased apoptotic and caspase-3-stained cells were observed in the cartilages of rats fed with normal and Se-deficient diets plus T-2 toxin exposure compared to those in rats fed with normal and Se-deficient diets. Caspase-3, p53, and Bax proteins and mRNA levels were higher, whereas Bcl-2 levels were lower in rats fed with normal or Se-deficiency diets supplemented with T-2 toxin than the corresponding levels in rats fed with normal diet. CONCLUSION: T-2 toxin under a selenium-deficient nutritional status induces chondrocyte death, which emphasizes the role of chondrocyte apoptosis in cartilage damage and progression of KBD.


Subject(s)
Apoptosis/drug effects , Cartilage, Articular/physiopathology , Chondrocytes/physiology , Kashin-Beck Disease/physiopathology , Selenium/deficiency , T-2 Toxin/pharmacology , Adolescent , Animals , Biomarkers , Child , Female , Humans , Kashin-Beck Disease/etiology , Male , Matrilin Proteins/genetics , Matrilin Proteins/metabolism , Models, Animal , Random Allocation , Rats , Rats, Sprague-Dawley
3.
Asia Pac J Clin Nutr ; 26(3): 406-411, 2017 May.
Article in English | MEDLINE | ID: mdl-28429904

ABSTRACT

BACKGROUND AND OBJECTIVES: The purpose of this study was to determine whether supplementation with lutein improved visual function in patients with nonproliferative diabetic retinopathy (NPDR). METHODS AND STUDY DESIGN: In this randomized, double-blind, placebo-controlled trial, 31 patients with NPDR were assigned randomly to 10 mg/d of lutein or identical placebo for 36 weeks. Visual performance indices, including visual acuity (VA), contrast sensitivity (CS) and glare sensitivity (GS) at four different spatial frequencies, were measured at baseline, week 18 and 36. RESULTS: At 36 weeks, a slight improvement in VA was found in the lutein group. A significant association was observed between the changes in VA and the corresponding baseline values in treatment group (r=-0.53; p=0.04). At 36 weeks, the lutein treatment group increased CS at four spatial frequencies, and the improvement achieved statistical significance at 3 cycles/degree (p=0.02). The changes in CS at 3 cycles/degree for the lutein group was marginally significantly greater than those for the placebo group (p=0.09). There was also a slight increase in GS in the lutein group up to week 36, however, no significant changes were found over time in any cycles/degree. CONCLUSIONS: In patients with NPDR, supplementation with lutein resulted in potential improvements in CS at low spatial frequency. Further studies are required to determine the possibility that such intervention could be used as an adjunct therapy to prevent vision loss in diabetic patients.


Subject(s)
Diabetic Retinopathy/drug therapy , Lutein/administration & dosage , Visual Acuity/drug effects , Aged , Contrast Sensitivity , Diabetic Retinopathy/physiopathology , Dietary Supplements , Double-Blind Method , Female , Humans , Male , Middle Aged , Placebos
4.
Food Chem Toxicol ; 58: 1-7, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23603382

ABSTRACT

Arsenic (As) is a toxic metalloid existing widely in the environment, and chronic exposure to it through contaminated drinking water has become a global problem of public health. The present study focused on the protective effects of selenium on oxidative damage of chronic arsenic poisoning in rat liver. Rats were divided into four groups at random and given designed treatments for 20 weeks. The oxidative damage of liver tissue was evaluated by lipid peroxidation and antioxidant enzymes. Oxidative stress related genes were detected to reflect the liver stress state at the molecular level. Compared to the control and Na2SeO3 groups, the MDA content in liver tissue was decreased and the activities of antioxidant enzymes were increased in the Na2SeO3 intervention group. The mRNA levels of SOD1, CAT, GPx and Txnrd1 were increased significantly (P<0.05) in the combined Na2SeO3+NaAsO2 treatment group. The expressions of HSP70 and HO-1 were significantly (P<0.05) increased in the NaAsO2 group and reduced in the combined treatment group. The results indicate that long-term intake of NaAsO2 causes oxidative damage in the rat liver, and Na2SeO3 protects liver cells by adjusting the expression of oxidative stress related genes to improve the activities of antioxidant enzymes.


Subject(s)
Arsenic Poisoning/genetics , Liver/drug effects , Oxidative Stress/drug effects , Selenium/pharmacology , Animals , Base Sequence , Catalase/genetics , Chronic Disease , DNA Primers , Glutathione Peroxidase/genetics , Liver/enzymology , Liver/metabolism , Malondialdehyde/metabolism , Oxidative Stress/genetics , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction , Superoxide Dismutase/genetics , Superoxide Dismutase-1 , Thioredoxin Reductase 1/genetics
5.
Article in Chinese | MEDLINE | ID: mdl-23595304

ABSTRACT

OBJECTIVE: To study the role of c-jun N-terminal kinase (JNK) signaling pathway in chondrocyte apoptosis induced by nitric oxide (NO) using NO donor sodium nitroprusside (SNP) and JNK inhibitor SP600125. METHODS: Articular chondrocytes were separated from New Zealand rabbits aged 3 weeks by mechanical digestion and enzyme digestion and identified by toluidine blue staining, and then the chondrocytes were treated with SNP and SP600125 for 24 h. The cell apoptosis was evaluated by Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) flow cytometry and terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL), and the expression levels of nuclear factor-kappa B (NF-κB) p65 and p53 were measured by western blot. RESULTS: Compared with those in control group, the early apoptotic rate of SNP-treated chondrocytes increased as the concentration of SNProse, exhibiting a concentration dependency (P < 0.05), and the expression levels of NF-κB p65 and p53 also increased (P < 0.05); JNK inhibitor SP600125 inhibited these increases (P < 0.05). CONCLUSION: JNK signaling pathway plays an important role in NO-induced chondrocyte apoptosis. JNK inhibitor SP600125 can reduce NO-induced apoptosis and expression of NF-κB p65 and p53 in articular chondrocytes of rabbits in a concentration-dependent manner.


Subject(s)
Apoptosis/drug effects , Chondrocytes/pathology , MAP Kinase Signaling System/drug effects , Nitric Oxide/pharmacology , Animals , Anthracenes/pharmacology , Cells, Cultured , Chondrocytes/drug effects , Chondrocytes/metabolism , NF-kappa B/metabolism , Rabbits , Transcription Factor RelA/metabolism , Tumor Suppressor Protein p53/metabolism
6.
Rheumatol Int ; 33(1): 157-66, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22258458

ABSTRACT

The objective of this study is to observe pathogenic lesions of joint cartilages in rats fed with T-2 toxin under a selenium deficiency nutrition status in order to determine possible etiological factors causing Kashin-Beck disease (KBD). Sprague-Dawley rats were fed selenium-deficient or control diets for 4 weeks prior to their being exposed to T-2 toxin. Six dietary groups were formed and studied 4 weeks later, i.e., controls, selenium-deficient, low T-2 toxin, high T-2 toxin, selenium-deficient diet plus low T-2 toxin, and selenium-deficient diet plus high T-2 toxin. Selenium deficiencies were confirmed by the determination of glutathione peroxidase activity and selenium levels in serum. The morphology and pathology (chondronecrosis) of knee joint cartilage of experimental rats were observed using light microscopy and the expression of proteoglycans was determined by histochemical staining. Chondronecrosis in deep zone of articular cartilage of knee joints was seen in both the low and high T-2 toxin plus selenium-deficient diet groups, these chondronecrotic lesions being very similar to chondronecrosis observed in human KBD. However, the chondronecrosis observed in the rat epiphyseal growth plates of animals treated with T-2 toxin alone or T-2 toxin plus selenium-deficient diets were not similar to that found in human KBD. Our results indicate that the rat can be used as a suitable animal model for studying etiological factors contributing to the pathogenesis (chondronecrosis) observed in human KBD. However, those changes seen in epiphyseal growth plate differ from those seen in human KBD probably because of the absence of growth plate closure in the rat.


Subject(s)
Cartilage Diseases/pathology , Cartilage, Articular/pathology , Kashin-Beck Disease/pathology , Selenium/deficiency , Stifle/pathology , T-2 Toxin/toxicity , Animal Feed/adverse effects , Animal Feed/analysis , Animals , Body Weight/drug effects , Cartilage Diseases/chemically induced , Cartilage, Articular/drug effects , Cartilage, Articular/metabolism , Chondrocytes/drug effects , Chondrocytes/metabolism , Chondrocytes/pathology , Disease Models, Animal , Dose-Response Relationship, Drug , Glutathione Peroxidase/blood , Growth Plate/drug effects , Growth Plate/pathology , Kashin-Beck Disease/physiopathology , Male , Necrosis/chemically induced , Necrosis/pathology , Proteoglycans/metabolism , Rats , Rats, Sprague-Dawley , Selenium/blood , Selenium/pharmacokinetics , Stifle/metabolism
7.
J Orthop Res ; 30(8): 1229-37, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22294316

ABSTRACT

Kashin-Beck disease (KBD) is an endemic degenerative osteoarthropathy, but the mechanisms underlying its pathogenesis remains unclear. This study compares antioxidant capacity and lipid peroxidation using a novel model, in which rats were administered a selenium-deficient diet for 4 weeks prior to their exposure to T-2 toxin for 4 weeks. Changes in cell morphology and empty chondrocyte lacunae indicative of cell death, as well as cartilage proteoglycan loss in the deep zone of articular cartilage of knee joints were observed in rats with selenium-deficient diet plus T-2 toxin treatment. These changes were similar to those observed previously in KBD. The levels of thiobarbituric acid reactive substances (TBARS), indicative of lipid peroxidation in serum and cartilage, were significantly increased in all experimental groups compared to the normal diet group, while the levels of antioxidants, measured as total antioxidant capacity (T-AOC), catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidases (GPX), in serum and cartilage were significantly lower than that in the normal diet group. The mRNA expression of those antioxidants in cartilage tissue was significantly reduced by T-2 toxin alone or by selenium-deficient diet plus T-2 toxin treatment. These results indicate that increasing TBARS and decreasing antioxidants in serum and cartilage by T-2 toxin treatment with a selenium-deficient nutritional status may alter oxidative stress in joint tissues and contribute to the pathological process of cartilage damage in KBD.


Subject(s)
Kashin-Beck Disease/physiopathology , Selenium/deficiency , T-2 Toxin/toxicity , Animals , Antioxidants/metabolism , Cartilage/metabolism , Cartilage, Articular/pathology , Catalase/metabolism , Child , Child, Preschool , Disease Models, Animal , Glutathione Peroxidase/metabolism , Humans , Lipid Peroxidation , Male , Oxidative Stress , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
8.
World J Gastroenterol ; 18(48): 7341-7, 2012 Dec 28.
Article in English | MEDLINE | ID: mdl-23326143

ABSTRACT

AIM: To compare early use of transjugular intrahepatic portosystemic shunt (TIPS) with endoscopic treatment (ET) for the prophylaxis of recurrent variceal bleeding. METHODS: In-patient data were collected from 190 patients between January 2007 and June 2010 who suffured from variceal bleeding. Patients who were older than 75 years; previously received surgical treatment or endoscopic therapy for variceal bleeding; and complicated with hepatic encephalopathy or hepatic cancer, were excluded from this research. Thirty-five cases lost to follow-up were also excluded. Retrospective analysis was done in 126 eligible cases. Among them, 64 patients received TIPS (TIPS group) while 62 patients received endoscopic therapy (ET group). The relevant data were collected by patient review or telephone calls. The occurrence of rebleeding, hepatic encephalopathy or other complications, survival rate and cost of treatment were compared between the two groups. RESULTS: During the follow-up period (median, 20.7 and 18.7 mo in TIPS and ET groups, respectively), rebleeding from any source occurred in 11 patients in the TIPS group as compared with 31 patients in the ET group (Kaplan-Meier analysis and log-rank test, P = 0.000). Rebleeding rates at any time point (6 wk, 1 year and 2 year) in the TIPS group were lower than in the ET group (Bonferroni correction α' = α/3). Eight patients in the TIPS group and 16 in the ET group died with the cumulative survival rates of 80.6% and 64.9% (Kaplan-Meier analysis and log-rank test χ(2) = 4.864, P = 0.02), respectively. There was no significant difference between the two groups with respect to 6-wk survival rates (Bonferroni correction α' = α/3). However, significant differences were observed between the two groups in the 1-year survival rates (92% and 79%) and the 2-year survival rates (89% and 64.9%) (Bonferroni correction α' = α/3). No significant differences were observed between the two treatment groups in the occurrence of hepatic encephalopathy (12 patients in TIPS group and 5 in ET group, Kaplan-Meier analysis and log-rank test, χ(2) = 3.103, P = 0.08). The average total cost for the TIPS group was higher than for ET group (Wilcxon-Mann Whitney test, 52 678 RMB vs 38,844 RMB, P < 0.05), but hospitalization frequency and hospital stay during follow-up period were lower (Wilcxon-Mann Whitney test, 0.4 d vs 1.3 d, P = 0.01; 5 d vs 19 d, P < 0.05). CONCLUSION: Early use of TIPS is more effective than endoscopic treatment in preventing variceal rebleeding and improving survival rate, and does not increase occurrence of hepatic encephalopathy.


Subject(s)
Endoscopy/methods , Esophageal and Gastric Varices/surgery , Gastrointestinal Hemorrhage/surgery , Portasystemic Shunt, Transjugular Intrahepatic/methods , Adult , Aged , Cyanoacrylates/chemistry , Digestive System Surgical Procedures/methods , Female , Follow-Up Studies , Humans , Hypertension, Portal , Inpatients , Male , Middle Aged , Postoperative Period , Recurrence , Time Factors , Treatment Outcome
9.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 38(2): 163-9, 2009 03.
Article in Chinese | MEDLINE | ID: mdl-19363824

ABSTRACT

OBJECTIVE: To observe the effect of Tanshinone II A on the expression of epidermal growth facter (EGF) and epidermal growth facter recepter (EGFR) in human hepatocellular carcinoma cell line SMMC-7721. METHODS: The human hepatocellular carcinoma SMMC-7721 cells cultured in vitro was treated with different concentrations of Tanshinone II A. The proliferation of the cells was measured by MTT assay, and the apoptosis of the cells was investigated by flow cytometry and cytochemical staining with Hoechst 33342. The expression of EGF and EGFR was detected by immunocytochemistry method. The levels of EGF in medium were measured by radioimmunoassay. RESULT: Tanshinone II A inhibited the growth of SMMC-7721 cells remarkably in a dose-dependent manner. The inhibitory rate reached the peak (72.5%) after 0.5 microg/ml Tanshinone II A was used for 48 h, which was significantly higher than that in the controls (P<0.05). FCM analysis showed that when SMMC-7721 cells were treated with 0.5 microg/ml Tanshinone II A, the apoptosis rates for 24 h, 48 h and 72 h were (4.06+/-0.27)%, (7.58+/-0.56)% and (5.23+/-0.13)%, respectively which were markedly higher than those in the controls (all P<0.01). SMMC-7721 cell apoptosis with cell shrinkage, nuclear chromatin concentration and fragmentation as well as the formation of apoptotic bodies were observed by cytochemical staining when treated with Tanshinone II A. The immunocytochemistry showed that the expressions of EGF and EGFR were down regulated while the concentration of Tanshinone II A was increasing. The high expression rates for EGF and EGFR were 10%, 20%, respectively, and the gray scale was 181.52+/-1.63, 179.37+/-1.59, which were markedly higher than those in the controls (all P<0.05). The levels of EGF in medium measured by radioimmunoassay were decreased significantly after Tanshinone II A treatment. CONCLUSION: Tanshinone II A can inhibit cell proliferation and induce apoptosis in hepatocellular carcinoma cell line SMMC-7721, which may be related to the down-regulation of EGF and EGFR protein expression.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Epidermal Growth Factor/metabolism , ErbB Receptors/metabolism , Liver Neoplasms/metabolism , Phenanthrenes/pharmacology , Abietanes , Apoptosis/drug effects , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Cell Proliferation , Down-Regulation/drug effects , Epidermal Growth Factor/genetics , ErbB Receptors/genetics , Humans , Liver Neoplasms/pathology
10.
J Zhejiang Univ Sci B ; 9(6): 455-63, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18543398

ABSTRACT

OBJECTIVE: To investigate the effects of T-2 toxin on expressions of Fas, p53, Bcl-xL, Bcl-2, Bax and caspase-3 on human chondrocytes. METHODS: Human chondrocytes were treated with T-2 toxin (1-20 ng/ml) for 5 d. Fas, p53 and other apoptosis-related proteins such as Bax, Bcl-2, Bcl-xL, caspase-3 were determined by Western blot analysis and their mRNA expressions were determined by reverse transcriptase-polymerase chain reaction (RT-PCR). RESULTS: Increases in Fas, p53 and the pro-apoptotic factor Bax protein and mRNA expressions and a decrease of the anti-apoptotic factor Bcl-xL were observed in a dose-dependent manner after exposures to 1-20 ng/ml T-2 toxin, while the expression of the anti-apoptotic factor Bcl-2 was unchanged. Meanwhile, T-2 toxin could also up-regulate the expressions of both pro-caspase-3 and caspase-3 in a dose-dependent manner. CONCLUSION: These data suggest a possible underlying molecular mechanism for T-2 toxin to induce the apoptosis signaling pathway in human chondrocytes by regulation of apoptosis-related proteins.


Subject(s)
Chondrocytes/drug effects , Chondrocytes/metabolism , T-2 Toxin/toxicity , Apoptosis/drug effects , Base Sequence , Blotting, Western , Caspase 3/genetics , Caspase 3/metabolism , Cell Proliferation/drug effects , Cells, Cultured , Chondrocytes/cytology , DNA Primers/genetics , Gene Expression/drug effects , Humans , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolism , bcl-X Protein/genetics , bcl-X Protein/metabolism , fas Receptor/genetics , fas Receptor/metabolism
11.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 15(1): 95-8, 2007 Feb.
Article in Chinese | MEDLINE | ID: mdl-17490530

ABSTRACT

The aim of this study was to find platelet specific autoantibodies against glycoproteins in myelodysplastic syndrome (MDS) and to explore its role in pathogenesis of MDS. The plasma autoantibodies against GP IIb/IIIa and GP Ib/IX were measured by using a modified monoclonal antibody specific immobolization platelet antigens assay (MAIPA). Absorbance greater than mean value plus tripled standard deviation recorded from the normal controls were regarded as positive. The results indicated that the total positive rate in patients with MDS was 16.67% (5/30), the total positive rate in patients with ITP was 46.67% (14/30), the difference between MDS group and ITP group was significant (P < 0.05). It is concluded that partial patients with MDS have plasma specific autoantibodies against platelet GP II b/III a and GP Ib/IX, indicating correlation of thrombocytopenia of patients with immune factors and the autoantibody-mediated platelet destruction may be involved in the pathogenesis of MDS. It provides a new basis for immunosuppression therapy for MDS.


Subject(s)
Autoantibodies/biosynthesis , Myelodysplastic Syndromes/immunology , Platelet Glycoprotein GPIIb-IIIa Complex/immunology , Platelet Glycoprotein GPIb-IX Complex/immunology , Adolescent , Adult , Aged , Antibodies/immunology , Antigens, Human Platelet/immunology , Autoantibodies/immunology , Female , Humans , Male , Middle Aged , Myelodysplastic Syndromes/complications , Thrombocytopenia/etiology , Thrombocytopenia/immunology
12.
Acta Odontol Scand ; 65(2): 65-71, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17453423

ABSTRACT

OBJECTIVE: The aim of the study was to assess dental fluorosis (DF) in the deciduous and permanent teeth of children in areas with high-F coal (area A) and high-F water (area C) compared to children from area B, with low-F water and coal. MATERIAL AND METHODS: 596 children were examined. DF was assessed by TF-score. F-content of indoor air, drinking water, coal, tea, rice, and maize was analyzed. RESULTS: F-content of air and coal ranged from 3.2 microg/m(3) and 25.8 mg/kg (area B), 3.8 microg/m(3) and 36.3 mg/kg (area C) to 56.8 microg/m(3) and 713.1 mg/kg (area A). Likewise, mean F-content of water ranged from approximately 0.50 mg/l (areas A and B) to 3.64 mg/l (area C). F-content of tea leaves was similar in all three areas. Maize and rice contained <5 mg F/kg. Prevalence of primary teeth with DF was 49.1%, 2.0%, and 66.8% in areas A, B, and C, respectively. Similarly, DF was found in 96.7% (area A), 19.6% (area B), and 94.4% (area C) of the permanent teeth. Severe fluorosis (TF > or = 5) was found in area A (47.0%) and area C (36.1%) (p<0.01). Early erupting teeth had slightly higher mean TF-scores in area A than in area C. CONCLUSIONS: DF was prevalent in both dentitions in areas A and C. Similarity in percentages of DF may indicate that indoor air with approximately 60 microg F/m(3) and drinking water with 3.6 mg F/L are similarly toxic to developing permanent teeth. The percentage of deciduous teeth with DF was significantly lower in area A compared to area C. Where low-F coal and low-F water were used (area B), approximately 20% of permanent teeth had DF, indicating a relatively low tolerance to fluoride in Chinese children brought up under the present living conditions.


Subject(s)
Air Pollutants/toxicity , Fluorosis, Dental/etiology , Water Pollutants, Chemical/toxicity , Adolescent , Child , China/epidemiology , Coal/adverse effects , Dentition, Permanent , Fluorosis, Dental/epidemiology , Food Contamination , Humans , Prevalence , Tea/chemistry , Tooth, Deciduous/drug effects
13.
Asia Pac J Clin Nutr ; 16 Suppl 1: 422-6, 2007.
Article in English | MEDLINE | ID: mdl-17392143

ABSTRACT

Trigonella foenum-graecum (fenugreek) seeds have previously been shown to have hypoglycemic and hypocholesterolemic effects on type 1 and type 2 diabetes mellitus patients and experimental diabetic animals. The Trigonella foenum-graecum extract has now been investigated for its effects on general properties, blood glucose and blood lipid, and hemorheological parameters in experimental diabetic rats. Streptozotocin-induced diabetic rats were administrated by oral intragastric intubation separately with low dose (0.44 g/kg.d), middle dose (0.87 g/kg.d), high dose (1.74 g/kg.d) of Trigonella foenum-graecum extract, and Metformin HCl (0.175 g/kg.d) for 6 weeks. Compared with diabetic group, rats treated with Trigonella foenum-graecum extract had an increase in body weight and a decrease in kidney /body weight ratio (p<0.05). Compared with diabetic group, rats treated Trigonella foenum-graecum extract had lower blood glucose, glycated hemoglobin, triglycerides, total cholestrol and higher higher-density-lipoprotein-cholesterol in a dose-dependent manner (p<0.05). The plasma viscosity, whole blood viscosity of high shear rate (200 s-1) and low shear rate (40 s-1), erythrocyte sedimentation rate, whole blood reduction viscosity and platelet conglutination were significantly reduced in diabetic rats treated with high and middle doses of Trigonella foenum-graecum extract, but not in those treated with low dose of Trigonella foenum-graecum extract. It may be concluded that Trigonella foenum-graecum extract can lower kidney /body weight ratio, blood glucose, blood lipid levels and improve hemorheological properties in experimental diabetic rats following repeated treatment for 6 weeks.


Subject(s)
Blood Glucose/drug effects , Diabetes Mellitus, Experimental/blood , Lipids/blood , Plant Extracts/pharmacology , Trigonella , Animals , Blood Glucose/metabolism , Blood Viscosity/drug effects , Diabetes Mellitus, Experimental/drug therapy , Dose-Response Relationship, Drug , Glycated Hemoglobin/analysis , Hypoglycemic Agents/pharmacology , Kidney/anatomy & histology , Kidney/drug effects , Male , Organ Size , Random Allocation , Rats , Rats, Sprague-Dawley , Seeds , Trigonella/chemistry
14.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 37(4): 583-6, 2006 Jul.
Article in Chinese | MEDLINE | ID: mdl-16909607

ABSTRACT

OBJECTIVE: To investigate the relationship of T-2 toxin-induced chondrocytes apoptosis with nitric oxide(NO) and Fas apoptosis pathway. METHODS: Human chondrocytes cultured in vitro were treated with different concentrations of T-2 toxin at different time (1-5 d). Cell viability of the treated cells was measured by MTT assay. Apoptotic ultrostructural changes of the treated cells were observed with electron microscopy. Biological changes of apoptosis were detected by annexin V/PI Flow cytometer (FCM). The levels of NO in culture media were detected by colorimetric method of Griess assay. Nitric oxide synthase (iNOS) and Fas protein were measured by Western blot. RESULTS: In this study the results shown the dose-dependent and time-dependent effects of T-2 toxin, within a range of concentration (1-2000 ng/mL) and a period of time (1-5 d), on the T-2 toxin-treated chondrocytes. Apoptotic body was found in T-2 toxin-treated chondrocytes by electron microscopy. Early-stage apoptosis rate and late-stage apoptosis rate were both increased in T-2 toxin-treated cells when compared with non-treated cells in a dose-dependent manner. The levels of NO in T-2 toxin-treated culture media were higher than that of normal control. Over-expressions of iNOS and Fas protein were detected in T-2 toxin-treated cells. T-2 toxin-induced apoptosis was noted to be significtnly correlated with the level of NO production and the levels of iNOS and Fas protein expression. CONCLUSION: T-2 toxin can enhance NO production and upregulate the expression of iNOS and Fas protein. Both NO and Fas signaling pathway are involved in T-2 toxin-induced apoptosis.


Subject(s)
Apoptosis/drug effects , Chondrocytes/cytology , Nitric Oxide/biosynthesis , T-2 Toxin/toxicity , fas Receptor/biosynthesis , Cells, Cultured , Chondrocytes/metabolism , Humans , Nitric Oxide Synthase Type II/biosynthesis
15.
Nan Fang Yi Ke Da Xue Xue Bao ; 26(4): 381-5, 2006 Apr.
Article in Chinese | MEDLINE | ID: mdl-16624732

ABSTRACT

OBJECTIVE: To study the inhibitory effect of T-2 toxin on the expression of aggrecan and collagen II in chondrocytes and the protection of selenium against this effect. METHODS: Human chondrocytes cultured in vitro were treated with T-2 toxin at different concentrations for varied time periods (1-5 days), and the cell viability was measured by MTT assay. Aggrecan expression was detected by toluidine blue staining and collagen II expression by immunostaining using monoclonal antibody of collagen. Aggrecan and collagen II mRNA expressions were measured by semiquantitative RT-PCR. RESULTS: T-2 toxin dose- and time-dependently affected chondrocyte viability within the concentration range of 0.001-2 mg/L, the prolonged treatment time further enhanced the dose dependence of the inhibitory effect. T-2 toxin lowered aggrecan and collagen II synthesis in the chondrocytes and reduced their mRNA expressions. Selenium could partly attenuate the inhibitory effects of T-2 toxin on aggrecan mRNA expression, but showed no such effect against T-2-induced collagen II expression. CONCLUSION: T-2 toxin can obviously inhibit aggrecan and collagen II synthesis in human chondrocytes, and selenium can partly antagonize the inhibitory effects of T-2 toxin on aggrecan.


Subject(s)
Aggrecans/biosynthesis , Chondrocytes/metabolism , Collagen Type II/biosynthesis , Selenium/pharmacology , T-2 Toxin/toxicity , Aggrecans/genetics , Cells, Cultured , Chondrocytes/cytology , Collagen Type II/genetics , Dose-Response Relationship, Drug , Fetus , Humans , Protective Agents/pharmacology , RNA, Messenger/biosynthesis , RNA, Messenger/genetics
16.
Acta Odontol Scand ; 63(5): 258-65, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16419430

ABSTRACT

OBJECTIVES: To study the dental fluorosis and caries in the permanent teeth of 12 to 13-year-old children in fluorosis-endemic areas; to assess the relationship between fluorosis and the fluoride content of the drinking water and the relationship between caries and the fluoride content of the water; finally, to analyze the effect of fluoride intake and water stored in clay pots on dental fluorosis. MATERIAL AND METHODS: 477 children were divided into 5 groups (A to E) according to the fluoride concentration of the waters, i.e. by 0.4, 1.0, 1.8, 3.5, and 5.6 mg F/l, respectively. Dental fluorosis was assessed by TF score and caries by the DMF-T index. A questionnaire was used to obtain information about water storage and other information relevant to children's fluoride intake. RESULTS: A positive relationship was found between the mean TF scores and the water fluoride concentration. In groups B and D, the TF score was higher in 13-year-olds than in 12-year-olds. Caries prevalence and mean DMF-T ranged from 2.6% and 0.03 (group E) to 22.1% and 0.38 (group A). Storage of water in clay pots seemed to increase the severity of fluorosis slightly, and to decrease the caries prevalence. CONCLUSIONS: Defluoridation of drinking water, or--alternatively--the provision of low-fluoride water sources, should be given high priority in the examined Shaanxi rural areas. Fluoride concentration of drinking water should be maximum 0.6 mg/l. Storage of water in the local clay pots may increase the severity of dental fluorosis.


Subject(s)
Cooking and Eating Utensils , Dental Caries/epidemiology , Fluorides/analysis , Fluorosis, Dental/epidemiology , Rural Population/statistics & numerical data , Water Supply/analysis , Adolescent , Aluminum Silicates , Child , China/epidemiology , Clay , Dentition, Permanent , Epidemiologic Methods , Female , Fluorides/toxicity , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...